au.\*:("WEANT, Kyle A")
Results 1 to 11 of 11
Selection :
Conversion from continuous insulin infusions to subcutaneous insulin in critically III patientsWEANT, Kyle A; LADHA, Alim.The Annals of pharmacotherapy. 2009, Vol 43, Num 4, pp 629-634, issn 1060-0280, 6 p.Article
The role of coenzyme Q10 in heart failureWEANT, Kyle A; SMITH, Kelly M.The Annals of pharmacotherapy. 2005, Vol 39, Num 9, pp 1522-1526, issn 1060-0280, 5 p.Article
Potential roles for statins in critically III patientsWEANT, Kyle A; COOK, Aaron M.Pharmacotherapy. 2007, Vol 27, Num 9, pp 1279-1296, issn 0277-0008, 18 p.Article
Postoperative hypertensionWEANT, Kyle A; FLYNN, Jeremy D; SMITH, Kelly M et al.Orthopedics (Thorofare). 2004, Vol 27, Num 11, pp 1159-1161, issn 0147-7447, 3 p.Article
Management of antiplatelet therapy for minimization of bleeding risk before cardiac surgeryWEANT, Kyle A; FLYNN, Jeremy E; AKERS, Wendell S et al.Pharmacotherapy. 2006, Vol 26, Num 11, pp 1616-1625, issn 0277-0008, 10 p.Article
High-Dose Methyiprednisolone in Acute Spinal Cord Injuries: Proceed With CautionPANDYA, Komal A; WEANT, Kyle A; COOK, Aaron M et al.Orthopedics (Thorofare). 2010, Vol 33, Num 5, pp 327-331, issn 0147-7447, 5 p.Article
Pharmacologic Options for Reducing the Shivering Response to Therapeutic HypothermiaWEANT, Kyle A; MARTIN, Julia E; HUMPHRIES, Roger L et al.Pharmacotherapy. 2010, Vol 30, Num 8, pp 830-841, issn 0277-0008, 12 p.Article
Evidence-Based, Multidisciplinary Approach to the Development of a Crotalidae Polyvalent Antivenin (CroFab) Protocol at a University HospitalWEANT, Kyle A; JOHNSON, Peter N; BOWERS, Rebecca C et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 3, pp 447-455, issn 1060-0280, 9 p.Article
Safety and Cost-Effectiveness of a Clinical Protocol Implemented to Standardize the Use of Crotalidae Polyvalent Immune Fab Antivenom at an Academic Medical CenterWEANT, Kyle A; BOWERS, Rebecca C; REED, Janelle et al.Pharmacotherapy. 2012, Vol 32, Num 5, pp 433-440, issn 0277-0008, 8 p.Article
ACUTE RELATIVE ADRENAL INSUFFICIENCY AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE. CommentaryWEANT, Kyle A; SASAKI-ADAMS, Deanna; DUMONT, Aaron S et al.Neurosurgery. 2008, Vol 63, Num 4, pp 645-650, issn 0148-396X, 6 p.Article
COST EFFECTIVENESS OF A CLINICAL PHARMACIST ON A NEUROSURGICAL TEAMWEANT, Kyle A; ARMITSTEAD, John A; LADHA, Alim M et al.Neurosurgery. 2009, Vol 65, Num 5, pp 946-951, issn 0148-396X, 6 p.Article